Themis Medicare Limited(BSE:530199 NSE:THEMISMED) ,Company Snapshot, Recent Developments, Latest News, Financials, Price Charts, Ratios, Contact Information

Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals

Home

News Centre

IPO

Markets	Companies	Research	Industries	E-Mail Page

my Last 5 Scrips
Company	BSE Price(Rs)	% Chg
Hindalco	108.95	1.27
Tata Stl	299.50	14.39
State Ba	2176.20	7.96
Bhel	195.80	3.74
Tata Mot	290.80	0.27
Clear All	Clear Last

NSE Live
Nifty Live Prices Live Quotes Top Gainers/Losers Top 10 Turnover No Delivery Stocks

BSE Live
BSE30 Live Prices Live Quotes Top Gainers/Losers Top 10 Turnover No Delivery Stocks

Market Pulse
Leaders Laggards FII Activity Mutual Fund Activity Meetings

Results Watch
Results Calendar Results Announced

IPO Watch

Company
Snapshots Quotes Charts Financials Recent News Broker Research Meetings Research Tutorial Discussion Forum

Research
Research Reports

Sector Watch

Economy Watch

Snapshot-Themis Medicare Limited

Themis Medicare Limited

Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:530199	NSE:THEMISMED	Bloomberg:TMCH@IN	Reuters:THEM.BO
Market Lot: 1	Face Value: 10	ISIN Demat: INE083B01016

Quotes	Snapshot	Charts	Financials	Research	Recent News
Peer Group	AGM/AM	MF Holding	Discussion Forum	BSE/NSE Notices	BSE/NSE Deals

Recent Developments
22-FEB-12 Gujarat Themis Biosyn (GTBL) will issue fresh shares of 29,28,702 at Rs. 5/- + premium of Rs. 5/- a share to Themis Medicare (TML). The company is being introduced as promoter of Gujarat Themis Biosyn by BIFR. 22-FEB-11 Themis Medicare said that the company has for the first time entered into an altogether new pharmaceutical marketing segment - Cosmeto ??? Dermatology with the launch of the brand LUMIXYL. 27-SEP-10 Themis Medicare t... More..
Business Profile	Future Plans

One To One

Latest News

Themis Medicare to hold 20.16% stake in Gujarat Themis Biosyn -IRIS 22-Feb-12

Brief Financials (in Rs. Mn.)

Period ending (months)	31-Dec-2012(9)	31-Mar-2012 (12)	31-Mar-2011 (12)
Net sales	1209.44	1348.57	2337.68
Other Income	34.16	21.78	52.08
Total Income	1243.60	1370.35	2389.76
Cost of goods sold	1145.97	1564.75	2155.87
OPBDIT	97.63	-194.40	233.89
PAT	-38.18	-346.74	101.37
Gross Block	-	-	-
Equity capital	80.50	80.51	80.51
EPS (Rs.)	-	-43.07	12.59
DPS (Rs.)	-	-	-
BV (Rs.)	-	-	-
P/E range (x)	-	NA	14.38 - 26.21
Debt / Equity (x)	-	-	-
Operating margin (% of OI)	7.9	-14.2	9.8
Net margin (% of OI)	-3.1	-25.3	4.2